Watson Pharmaceuticals, Inc. operates in the Pharmaceutical preparations sector. Watson Pharmaceuticals, Inc. (Watson) is an integrated global pharmaceutical company engaged in the development, manufacturing, marketing, sale and distribution of generic and brand pharmaceutical products. The Company operates in three segments: Global Generics, Global Brands and Distribution. It operates in international markets, including Western Europe, Canada, Australasia, Asia, South America and South Africa with its commercial market being the United States of America. As of December 31, 2010, it marketed approximately 160 generic pharmaceutical product families and approximately 30 brand pharmaceutical product families in the United States and a number of product families internationally through its Global Generics and Global Brands Divisions, respectively, and distributed approximately 8,500 stock-keeping units (SKUs). In May 2011, it acquired Specifar Pharmaceuticals S.A. In January 2012, Strides Arcolab Limited sold 94% holding in Ascent Pharmahealth Limited to Watson. In our complete report available for purchase the company is compared to: Celgene Corporation, Hospira, Incorporated and Forest Laboratories, Inc..